CeLLogix allogenic bone scaffold
bone allograft containing viable bone-derived cells

CeLLogix cellular bone matrix is a viable allogeneic bone allograft containing viable bone-derived cells

CeLLogix is prepared with a novel DMSO-free cryoprotectant, which provides dependable cell identity and the ability to sustain cell viability post-thaw. Final preparation of the cell and bone components yields a product that provides osteoconductive, osteoinductive, and osteogenic properties to enhance the patient’s innate healing response.

CeLLogix contains the three key elements that are ideal for bone formation

An osteoconductive three-dimensional scaffold with cortical and cancellous components.

A demineralized bone scaffold with osteoinductive potential.¹

Viable spine-derived cells to support osteogenesis.

CeLLogix Product Features

Proprietary, optimized bone microparticulate size range of 100-300 μm²

Novel DMSO-free cryoprotectant, with no rinsing and decanting steps required.

Average cell viability exceeds 80% post-thaw¹

Minimum of 150,000 viable cells per cc of allograft post-thaw¹

Convenient handling and preparation time in the OR

Four hour working window for implantation after thaw without loss of cell viability

Product shelf-life is two years from date of processing when stored at -65°C or colder


1. Data on file at VIVEX Biologics, Inc.

2. Malinin, T.I., et. al., Particulate bone allograft incorporation in regeneration of osseous defects; importance of particle sizes. The Open Orthopeadics Journal, 2007. 1:19-24.

Product Brochure

Omnia Medical CeLLogix Product Brochure

Instant Download

Omnia Medical CeLLogix Product Brochure